Kui Zhao Selected Research

Class I Phosphatidylinositol 3-Kinases

5/2013	[Effects of class I( phosphatidylinositol-3-kinases inhibitor on gastric cancer cell xenografts in nude mice].
10/2009	Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kui Zhao Research Topics

Disease

33	Neoplasms (Cancer) 08/2022 - 12/2008
24	Infections 06/2022 - 10/2000
11	Neoplasm Metastasis (Metastasis) 05/2022 - 08/2009
10	Stomach Neoplasms (Stomach Cancer) 03/2021 - 10/2009
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2009
8	Carcinoma (Carcinomatosis) 09/2018 - 12/2008
7	Carcinogenesis 09/2022 - 10/2000
4	Cytokine Release Syndrome 01/2022 - 02/2018
4	Encephalomyelitis (Myeloencephalitis) 01/2021 - 07/2012
3	Adenocarcinoma 01/2022 - 11/2013
3	Inflammation (Inflammations) 11/2021 - 10/2000
3	Lymphoma (Lymphomas) 12/2020 - 01/2014
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 08/2014
3	Vesicular Stomatitis 12/2017 - 03/2013
3	Virus Diseases (Viral Diseases) 09/2017 - 09/2010
3	Necrosis 05/2017 - 12/2008
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2022 - 09/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022 - 01/2021
2	Nasopharyngeal Carcinoma 12/2021 - 01/2021
2	Brain Injuries (Brain Injury) 12/2021 - 01/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2019
2	Rectal Fistula (Anal Fistula) 07/2018 - 09/2012
2	Fistula 07/2018 - 09/2012
2	Squamous Cell Carcinoma of Head and Neck 06/2018 - 10/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2015
2	Hypoxia (Hypoxemia) 05/2017 - 04/2014
2	Infarction (Infarctions) 02/2017 - 12/2004
2	Fever of Unknown Origin 01/2014 - 02/2011
2	Contagious Ecthyma 04/2013 - 12/2011
1	Heavy Metal Poisoning 06/2022
1	Poisoning 05/2022
1	Hemangiosarcoma (Angiosarcoma) 05/2022
1	Craniopharyngioma (Craniopharyngiomas) 04/2022
1	Pathologic Constriction (Stenosis) 04/2022
1	Anemia 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 04/2021 - 12/2008
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2022 - 12/2015
8	Antiviral Agents (Antivirals)IBA 02/2022 - 09/2010
7	CytokinesIBA 01/2022 - 02/2013
7	Chimeric Antigen ReceptorsIBA 01/2021 - 02/2018
5	Long Noncoding RNAIBA 01/2021 - 01/2016
4	AntigensIBA 01/2022 - 11/2013
4	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 04/2014
4	Messenger RNA (mRNA)IBA 04/2019 - 12/2008
4	Small Interfering RNA (siRNA)IBA 09/2017 - 09/2010
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2018
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
3	VaccinesIBA 01/2016 - 12/2011
3	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 12/2013 - 10/2009
2	SeleniumIBA 12/2022 - 09/2022
2	AntioxidantsIBA 06/2022 - 05/2022
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2021 - 08/2014
2	HMGB1 Protein (HMG1)IBA 04/2021 - 01/2015
2	Carcinoembryonic AntigenIBA 01/2021 - 10/2011
2	Cadherins (E-Cadherin)IBA 01/2021 - 05/2013
2	Monoclonal AntibodiesIBA 12/2020 - 03/2013
2	RNA (Ribonucleic Acid)IBA 02/2020 - 09/2018
2	16S Ribosomal RNAIBA 01/2020 - 07/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019 - 04/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2018
2	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 07/2018 - 09/2012
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2015 - 09/2010
2	Beclin-1IBA 08/2014 - 07/2014
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2014 - 05/2011
2	Fluorine-18IBA 01/2014 - 02/2011
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2013 - 11/2011
2	Class I Phosphatidylinositol 3-KinasesIBA 05/2013 - 10/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2009 - 12/2004
1	Competitive Endogenous RNAIBA 09/2022
1	NocodazoleIBA 06/2022
1	molybdate (molybdate ion)IBA 06/2022
1	MolybdenumIBA 06/2022
1	Histone Deacetylase 6IBA 06/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2022
1	FertilizersIBA 06/2022
1	ammonium molybdateIBA 06/2022
1	PotassiumIBA 06/2022
1	Viral RNAIBA 06/2022
1	Heavy MetalsIBA 05/2022
1	Hemoglobins (Hemoglobin)IBA 05/2022
1	Ferritins (Ferritin)IBA 05/2022
1	fluoromethylcholineIBA 04/2022
1	Polysaccharides (Glycans)IBA 02/2022
1	FluorineIBA 01/2022
1	sintilimabIBA 01/2022
1	pyridineIBA 01/2022
1	AcidsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	Protective AgentsIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022

Therapy/Procedure

16	Therapeutics 02/2022 - 09/2010
11	Radiotherapy 08/2022 - 12/2008
10	Drug Therapy (Chemotherapy) 04/2021 - 06/2013
6	Aftercare (After-Treatment) 07/2019 - 12/2008
2	Fecal Microbiota Transplantation 01/2020 - 07/2019
1	Decompression 04/2022